(Q45875551)

17 December 2017

title

Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells (English)

1 reference

17 December 2017

1 reference

D P Hart

1

1 reference

17 December 2017

S-A Xue

2

1 reference

17 December 2017

S Thomas

3

1 reference

17 December 2017

M Cesco-Gaspere

4

1 reference

17 December 2017

A Tranter

5

1 reference

17 December 2017

B Willcox

6

1 reference

17 December 2017

S P Lee

7

1 reference

17 December 2017

N Steven

8

1 reference

17 December 2017

E C Morris

9

1 reference

17 December 2017

H J Stauss

10

1 reference

17 December 2017

publication date

28 February 2008

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

625-631

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3303078

exact match

0 references

cites work

Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Immunotherapy through TCR gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Designer T cells by T cell receptor replacement.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Retroviral vectors for high-level transgene expression in T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Facilitating matched pairing and expression of TCR chains introduced into human T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303078

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3303078

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017